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Abstract
Nearly 24 million people are affected by autoimmune diseases in the United States. Main
causes of autoimmune diseases have been attributed to genetic predisposition and environmental
exposure to chemicals such as hormones and pesticides. Due to the large population that are
affected by autoimmune diseases, it is critical to understand the mechanisms behind them. In this
study, we sought to explore both genetic and environmental factors that affect hematopoiesis, or
the formation of specific blood cells, and immune system in Drosophila melanogaster. As
Drosophila melanogaster have conserved pathways of hematopoiesis as humans, they were used
as the model organism for the study. We examined the presence of lamellocytes, a type of
Drosophila blood cell typically only present upon immune challenge by wasp parasitoids, across
Drosophila Genetic Reference Panel (DGRP) lines. We then conducted a Genome Wide
Association Study (GWAS) to identify single nucleotide polymorphisms (SNPs) that lead to
lamellocyte induction without any immune challenges. Post-GWAS bioinformatic analyses were
used to characterize the genes where the SNPs were found. Drosophila were then treated with
Methoprene, a common insecticide, to observe its effect on lamellocyte production.
Unexpectedly, 4 DGRP lines showed lamellocyte production without any immune challenges.
GWAS showed 365 SNPs associated with the lamellocyte phenotype. Post-GWAS results
provided 44 genes that were associated with hematopoiesis and the immune system. In addition,
Methoprene treatments induced lamellocytes in all DGRP lines used in the study. Future studies
with this study include measuring the expression levels of immune system related genes upon
Methoprene treatment to understand possible Methoprene genetic targets and their mechanisms
to induce lamellocytes.
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Introduction
Immune System
Immune systems are essential to defending our body from infections and pathogens. They
are complex systems that involve different cells, tissues and organ systems. The main functions
of the immune system include neutralizing and removing foreign pathogens and fighting against
the body’s own cells that have become nonfunctional and dangerous to the body (Chaplin, 2006).
Humans have both innate and adaptive immune systems. The innate immune response is a
nonspecific response that is often triggered by general foreign pathogens such as bacteria
(Chaplin, 2006). On the contrary, the adaptive immune system responds by producing specific
agents that target specific pathogens that have already been introduced to the body (Chaplin,
2006).
The innate immune response occurs faster than the adaptive immune response. It works
by recognizing and then engulfing harmful foreign agents in the body. Additionally, there are
other signaling molecules that the body releases that communicate to the innate immune cells to
fight against infections (Chaplin, 2006). When the innate immune response occurs, inflammation
follows. Furthermore, innate immunity is important because when the cells within the innate
immune system engulfs the foreign agents, it can help activate the adaptive immune responses
(Thompson, 2015).
Drosophila melanogaster are a good model organism to study innate immunity. They
have a primitive yet conserved hematopoietic system, or the formation of the blood cells
responsible for immune response, that can be modified in order to study the mammalian blood
cells. Some critical hematopoietic signaling pathways such as Notch, Hedgehog, and Wingless
(WNT) are conserved in the Drosophila model (Wang et al., 2014). Their simple genome allows
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for less complex signaling pathways to be studied as compared to the mammalian systems
(Wang et al., 2014).

Immune Disorders
Autoimmune diseases are recognized by immune system cells attacking healthy cells.
Some common autoimmune diseases include type 1 diabetes, systemic lupus erythematosus, and
rheumatoid arthritis. Autoimmune diseases are often not considered as public health issues, but
they are one of the leading causes of death among many populations. About 23.5 million
Americans suffer from autoimmune diseases according to the National Institutes of Health.
However, the NIH dataset only incorporates 24 autoimmune diseases that epidemiological
studies have been conducted for out of 80-100 autoimmune diseases that scientists have
identified (AARDA). Although these diseases affect a large portion of the population, they do
not receive as much attention as other public health issues.
Although there has not been a definitive answer to what causes autoimmune diseases,
most have been attributed to genetic and environmental triggers. For instance, studies have
indicated that genetic background affects autoimmune disease development in response to
environmental triggers such as insecticides or other chemicals (Vojdani, Pollard, and Campbell,
2014). For example, exposure to organic solvents has been linked to causing scleroderma, an
autoimmune disease of the rheumatis (Kettaneh et al, 2007). Other environmental triggers of
autoimmune diseases include silica, asbestos, and certain drugs like procainamide (Pollard,
Hultman, and Kono, 2010). Endocrine disrupting chemicals have also contributed to causing
autoimmune diseases (Edwards and Myers, 2007). Multiple mechanisms of gene regulations
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have been proposed to be affected by environmental exposures of chemicals such as histone
modification, DNA methylation, and gene translocation (Edwards and Myers, 2007).

Immune System Development and Hematopoiesis in Drosophila melanogaster
Hematopoiesis is the process of the formation of the blood cells responsible for immune
responses. There are two stages of hematopoiesis. In mammals, the hematopoietic stem cells
(HSCs) that will eventually differentiate into blood cells are formed during the embryonic stage
(Tavian, 2010). The definitive hematopoiesis occurs in the later adult stages. During this time,
the HSCs differentiate into all types of adult blood cells (Jagannathan-Bogdan and Zon, 2017).
Similarly, the differentiation into specific blood cells occur in two stages of hematopoiesis in
Drosophila melanogaster (Meister and Lagueux, 2003).
The first stage of hematopoiesis occurs during the embryonic stage. At the head
mesoderm of the embryos, fixed number of lineages and hemocytes are formed (Crozatier and
Meister, 2007). It is when the larva reaches the third instar larval stage that hemocyte
differentiation occurs (Crozatier and Meister, 2007). In unchallenged, normal conditions, the
prohemocytes differentiate predominantly into plasmatocytes at the onset of metamorphosis
(Crozatier and Meister, 2007). A small portion, about 5%, differentiate into crystal cells (Wang
et al., 2014). Upon metamorphosis, the larval lymph gland disintegrates and allows the
hemocytes to circulate (Crozatier and Meister, 2007).
The three distinguished Drosophila blood cells are plasmatocytes, crystal cells, and
lamellocytes. The plasmatocytes function similarly to macrophages, in which they phagocytize
cell debris, foreign pathogens, and other harmful molecules (Wang et al., 2014). They are the
most abundant form of blood cells. Crystal cells are responsible for the melanization and
5

coagulation of hemocytes at infected sites for killing pathogens, preventing loss of hemocytes,
and wound healing (Wang et al., 2014). Finally, lamellocytes are a type of hemocytes that are
induced only during infection from a pathogen. When the larva is challenged by foreign
pathogens, premature hemocyte differentiation occurs before the onset of metamorphosis
(Crozatier and Meister, 2007). They are larger, and flatter compared to the plasmatocytes and
crystal cells (Wang et al., 2014). They encapsulate the foreign pathogens, mostly parasitoid eggs,
and also signal plasmatocytes to fight them (Sorrentino et al., 2002).
The function of the lamellocytes is similar to the function of granulomas, collection of
immune cells responsible for encapsulating foreign agents such as bacteria, in vertebrates
(Markus et al., 2009; Mukhopadhyay et al., 2011). There has not been definitive location of
where lamellocyte formation occurs, but it has been suggested that it likely occurs in both the
sessile hemocyte compartments and in the larval lymph gland, which is generally the
hematopoietic organ in the Drosophila, when immune challenge from parasitization occurs
(Markus et al., 2009). Many species of Drosophila and other insects are parasitized in the larval
stage by parasitoid including wasps. These organisms use insects as host species to house eggs
that eventually hatch and consume the host while developing.
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Figure 1: Hematopoietic pathways of Drosophila blood cells. Lamellocytes can be formed by
differentiation from prohemocytes through the JAK/STAT or Toll pathway. It can also be formed through
transdifferentiation of plasmatocytes by Srp and Chn genes. Figure adapted from Wang, Kounatidis, and
Ligoxygakis (2014).

Numerous studies have been conducted to understand the signaling pathways of
hematopoietic stem cell differentiation in Drosophila melanogaster. Lamellocyte differentiation
in the lymph gland is regulated by JAK-STAT pathway (Lemaitre, Bruno, and Jules Hoffmann,
2007). Lamellocyte transdifferentiation from circulating hemocytes is caused by Srp and Chn
(Anderl et al., 2016). Notch function in the Notch signaling pathway is important for lamellocyte
proliferation upon parasitization (Duvic et al., 2002). These signaling pathways are important not
only for hemocyte differentiation, but also for other functions in both Drosophila as well as in
humans.
Dysregulation of Notch signaling pathway has been connected to cancer and Alzheimer’s
diseases as it is important in cell-to-cell communication (Kopan, and Ilagan, 2009). More
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importantly, Notch signaling dysfunction has been linked to development of autoimmune
diseases (Talora et al., 2008). Furthermore, the JAK-STAT pathway is a pleiotropic one that is
involved in multiple biological processes hematopoiesis, immune development, mammary gland
development and lactation, adipogenesis, sexually dimorphic growth and other processes
(Rawlings, 2004). Mutations in this pathway has also been implicated in causing autoimmune
diseases and immunodeficiencies (Banerjee et al., 2017).

Juvenile Hormone in Development and Juvenile Hormone Mimics
There are two hormone groups that
play major roles in insect development, the
steroidal hormones and juvenile hormones
(JH). One steroidal hormone, 20hydroxyecdysterone (20E), is particularly
important in the formation of the immune
system. The main function of 20E is to initiate
progression into the next stage in the insect
life cycle (Dubrovsky, 2005). Additionally,
20E signals hemocyte motility, upregulate
Figure 2: Life cycle of Drosophila melanogaster.
JH is present during the transition to the next stage
of the life cycle from egg until pupal stage. From
the Carolina Biological Supply Company

actin dynamics and phagocytosis (Reagan et
al., 2013).

JH operates by modulating progressions of the stages of the Drosophila (Dubrovsky,
2005). JH is present in each stage of the metamorphosis from egg until the pupal stage. They are
necessary for proper transition into the next stage in the life cycle especially in controlling the
timing of development (Riddiford et al., 2010). The receptors of where JH binds to have been
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shown to be Met-tolerant (Met) and germ cell expressed (gce) (Riddiford, 2012). JH has also
been studied to influence the Drosophila immune system as hormonal immune-suppressor (Flatt
et al., 2008). Proper regulation of these two hormones lead to successful development of insects.
Juvenile Hormone mimics have been used as a tool in research to study the role of
Juvenile Hormones in development. The Juvenile Hormone mimics have similar structures as the
endogenous JH which enables them to be key tools (Baumann et al., 2017). Some examples of
Juvenile Hormone mimics include Methoprene and Pyriproxyfen. Juvenile Hormone mimics
have also been used as larvicides due to the roles they play in development (Baumann et al.,
2017). The Juvenile Hormone mimics disrupt embryonic development, causes mortality in pupal
development, and leads to sterility in some adult species (Retnakaran and Granett, 1985;
Riddiford, 1970; Staal, 1975). Because of its fatal effects in development, Juvenile Hormone
mimics like Methoprene have been used against insects such as mosquitoes, flies, and fleas
(Wick et al., 2012).
Methoprene is a Juvenile Hormone mimic that has been used as an insecticide since 1975
(Wick et al., 2012). It is a common chemical used in over 500 pesticides due to its ability to
inhibit pest development. Because of its common use in agriculture, it is likely to be exposed
upon consumption of certain types of food such as cereal (Wick et al., 2012).

Genome Wide Association Studies (GWAS)
The Genome Wide Association Study (GWAS) is a bioinformatic method that is
commonly used to identify genetic risk factors of a disease in a population (Bush and Moore,
2012). GWAS searches for enrichment of polymorphisms within diseased or susceptible
individuals. These polymorphisms, often single nucleotides (SNPs) are usually used as markers
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of genomic regions but sometimes also have functional significances such as changing mRNA
stability or amino acid changes (Bush and Moore, 2012). It is a useful method for detecting
genetic susceptibility as well as for new personalized therapeutics (Bush and Moore, 2012).
GWAS was used in this study because identifying genes in which the single nucleotide
polymorphisms occur allows to draw connections between phenotypes and genes. It was possible
to conduct GWAS studies on Drosophila Genetic Reference Panel (DGRP) lines, the fly lines
used in this study, as all the genomes have been fully sequenced and polymorphisms detected
(Mackay et al, 2012).
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Objectives
As causes of autoimmune diseases are attributed to both genetics and environmental factors,
this study will investigate how both factors affect the immune system in Drosophila
melanogaster. First, it intends to address the genes involved in the Drosophila hematopoietic
pathways using Genome Wide Association Study (GWAS) to identify the genes associated with
the induction of lamellocytes in its normal environment. Then, it seeks to observe the effects of
Methoprene, a commonly found environmental factor, on Drosophila lamellocyte induction.
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Materials and Methods
Fly lines
The main fly lines used were the Drosophila Genome Reference Panel (DGRP) lines.
They were chosen to be used because all genotypes have been fully sequenced, and they have
been inbred to near homozygosity for each allele (Mackay et al., 2012). All fly lines used for
experiments were ordered from the Bloomington Stock Center. Specific genotypes within the
DGRP lines were chosen based on previous experiments done for average number of crystal cells
in the Spokony lab. They were chosen so that there was a normal distribution of average crystal
cell numbers.
As the wildtype and control genotype, the Oregon-R-modENCODE 25211 line was used
because it matches literature for wildtype genotypes to have an average of 50 crystal cells per
larva.
At the inception of this study, GFP-labeled Drosophila lines were used to confirm the
shapes for each hemocyte type. The hemese-Gal4>UAS-GFP (Bloomington Stock – 8700) labels
all hemocytes (Hultmark, 2005). Lozenge-Gal4>UAS-GFP (Bloomington Stock – 6314) labels
crystal cells (Pollock, 2001).10XStat92e-GFP (Bloomington Stock – 26197) all have hemocytes
tagged with GFP (Bach et al, 2008).
Another genotype, hopTum-1, was used to confirm the shape of lamellocytes. This
particular genotype has a mutation so that the hopscotch gene is constitutively active in a way
that induces lamellocyte formation without any immune challenges from parasitoid wasps (Luo,
2004).
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All fly lines were maintained in standard agarose food vials with active dry yeast from
Red Star. The experimental flies were maintained at 25°C and stock flies were maintained in
17°C conditions.

Ethanol and Methoprene Treatments
Ethanol was used as another control group for the experiment as it is found in fermented
food that fruit flies normally consume. For each genotype, 2 vials of 8 females and 3 males were
set up for treatment. Each set up vial were tossed onto new vial of food consecutively for 3 days.
On the 4th day, the flies were tossed into the morgue to have 4 sets of vials with only the larvae.
On the 4th day of each vial, the food was treated with either 25μl of ethanol or 25μl of 1μl/mL
Methoprene in ethanol.

Immunofluorescence Cytochemistry
3rd instar larvae were used to observe hemocyte characteristics. For each genotype, at
least 6, but on average, 12 larvae were used to observe the presence or absence of lamellocytes.
A minimum of 4 wells were made per genotype: 2 male and 2 female wells, each with 2-3 larvae
per well.
On a Superfrost plus pre-cleaned slide, two hydrophobic wells were drawn with a
hydrophobic liquid blocker PAP pen. Separated by sex, 2-3 clean larvae were bled into the well
containing 40-50μl of 1X Phosphate Buffered Saline (1X-PBS) by cutting open the larvae. Once
the cells were settled onto the slide for 20-30 minutes, 12.5μl of 16% formaldehyde from Ted
Pella, INC were added onto the wells for 15 minutes. The wells were washed with 40-50μl of
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1xPBS and with 0.3% Triton X-100 (1X PBS-T) two times for 10 minutes each. The wells were
filled with 40-50μl of 10% Normal Donkey Serum (NDS) blocking solution and placed in a 4°C
freezer overnight.
The following day, the 10% NDS blocking solution was removed and replaced with a
new blocking solution along with 1μl phalloidin per well. After exposure to the solution for 1
hour at room temperature, the wells were washed with 40-50μl of 1X PBS two times for 10
minutes each. 40-50μl of 1X PBS-T and 1μl Hosecht 33342 from Invitrogen were then added
into each of the wells for 10 minutes. The wells were next washed with 40-50μl of 1X PBS two
times for 10 minutes each. Two drops of 25% glycerol were added into each well then covered
with a coverslip.

Hemocyte Characterization
The stained hemocytes were observed under ZEISS Axio Vert A1 Microscope with
AxioCam MRm Software. The blue fluorescent light was used to observe the phalloidin, the
stain for actin, which indicated the cell structures. The purple fluorescent light was used to
observe the DAPI, which indicated the nucleus of the cells.
Each well was classified for the presence or absence of plasmatocytes, crystal cells, and
lamellocytes based on the physical characteristics described and illustrated in previous studies.
The macrophage looking plasmatocytes were categorized based on their pseudopod like
extensions. The crystal cells were categorized from their circular shape and crystal resembling
structure inside the cells. The lamellocytes were the easiest to classify as they are the largest type
of hemocytes in the Drosophila immune system. The wells were observed under 200x
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magnification with the eyepiece. The images were taken with additional magnification at 2000x.
At least one image was taken to show the hemocytes under the blue fluorescent light, purple
fluorescent light, and bright light. The field of view for the image taken was 0.6μm by 0.6μm.
Black and white images were then captured using the AxioVision imaging software.
ImageJ software was used to add the colors to the fluorescent cells so that the images may be
merged to show the cell structure and nucleus. Green indicates the phalloidin and blue indicates
the Hoescht in all the images shown in the study.

Genome Wide Association Study (GWAS)
GWAS was completed only for the untreated DGRP lines as few lines showed the
presence of lamellocytes under untreated conditions. It was conducted through submission to the
North Carolina State University official DGRP website (dgrp2.gnets.ncsu.edu) (Mackay et al.,
2012). The DGRP line number and the phenotype presence was submitted into the DGRP
pipeline. When submitted, the pipeline provides associated SNPs with the phenotypes as well as
additional information including the common distribution of the variants.
Although it was previously planned to conduct GWAS after Methoprene treatment of the
DGRP lines had been conducted, it was impossible to do so as all lines upon treatment showed
presence of lamellocytes.
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Post-GWAS Bioinformatic Methods
FlyMine
FlyMine is a website of integrated database of Drosophila genomics (Lynn et al., 2007).
It provides detailed information such as loci of expression, ontology, and presence in genetic
pathways. The resulting hits from the GWAS were put into the FlyMine database for preliminary
characterization of the genes assigned to the SNPs.
Fly Atlas
The FlyAtlas is a dataset of expression levels of majority of known Drosophila genes
(Chintapalli, Wang, Dow, and Herzyk, 2007). It is embedded into the FlyMine site so that when
a list of genes is searched in FlyMine, gene expression results from Fly Atlas also are provided.
Drosophila RNAi Screening Center Integrative Ortholog Prediction Tool (DIOPT)
The DIOPT tool (www.flyrnai.org/diopt) allows for rapid identification of orthologs
between certain organisms (Hu et al., 2011). The DIOPT Diseases and Traits (DIOPT-DIST)
section uses Online Mendelian Inheritance in Man (OMIM) and Genome Wide Association
Studies (GWAS) databases to provide human diseases related to the gene searched. The DIOPT
scores are based on the level of protein alignment between the comparing organisms.
The gene ontology and function were organized by FlyMine were organized to focus on
genes related to hematopoiesis and immune system. Each gene in this category were searched for
in the DIOPT-DIST database to observe which human diseases these genes were orthologues to.
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Results
Part I: Characterization of Hemocytes
To identify the lamellocytes, immunofluorescence cytochemistry staining was used. The
stained slides were captured under a microscope with fluorescent light to visualize the cell
structure and presence of a nucleus. All of the images in the results section show the merged
images of the same field of view with blue fluorescent light and UV light under either 2000x or
4000x magnification.

Plasmatocytes

Crystal Cells

Lamellocytes

Figure 3: Three types of hemocytes of Drosophila melanogaster. Green= GFP labeled phalloidin,
Blue= Hoescht DNA Stain. Green indicates cell structure. Blue indicates cell nucleus. Red arrows
indicate lamellocytes. All slides observed under 200x magnification.

The hemocytes were characterized by their shapes: cells with pseudopods were classified
as plasmatocytes, circular cells with smaller crystals were classified as crystal cells, and large,
flat cells were classified as lamellocytes as established by Wang et al (2014). They were
confirmed to be individual cells through the stain for the nuclei of the cells. The plasmatocytes
have pseudopod like structures that extend from the cell. The crystal cells are the smallest of the
three types of hemocytes. They are circular in shape and have crystal like structures in their cells.
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The lamellocytes are the biggest hemocytes out of the cell. As can be seen in the figures above,
lamellocytes are at least 3 times larger than plasmatocytes.
Four genotypes were used to confirm the shape of the lamellocytes in addition to the
Oregon-R-modENCODE fly. The hopTum-1, hemese-Gal4, lozenge-Gal4, and the 10xStat92e-GFP
genotypes all have hemocytes tagged with GFP.
Mutants with constitutively active HOP (hoptum-1) produce an excess of lamellocytes in
A
the absence of parasitization. We used them as a positive control for the presence of
lamellocytes. The lamellocytes of the hoptum-1 genotype showed us the structure of how
lamellocytes should look like (Figure 4). It was used as the standard for observing for the
presence of lamellocytes in the DGRP lines. They are much larger than plasmatocytes and
crystal cells. They are often leaf-shaped or banana-shaped.

A

B

Figure 4: Lamellocytes from the hoptum-1 genotype. A) Lamellocytes under fluorescent light at 400x
magnification. Red arrows indicate to lamellocytes. Green indicates the phalloidin stain. Blue indicates
the nucleus from the Hoescht stain. B) Lamellocytes under regular light at 400x magnification. Red
arrows indicate to lamellocytes.
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The Oregon-R-modENCODE was used as the control genotype to observe the effects of
Methoprene treatment (Figure 5). Lamellocytes are only present under Methoprene treatment. In
the untreated and ethanol treated larva, only plasmatocytes and crystal cells were present.

Untreated
Female

Ethanol Treated
Female

Methoprene Treated
Female

Figure 5: Images of stained hemocyte of untreated, ethanol-treated, Methoprene-treated Oregon-RmodENCODE larvae. Green (GFP) indicates cell structure. Blue (Hoescht) indicates cell nucleus. Red
arrows indicate lamellocytes. All slides observed under 200x magnification.
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Part II: Natural Variation of Lamellocyte Formation
Untreated DGRP lines with lamellocyte formation

Figure 6: Image of 28223 male larvae hemocyte bleeds without any treatment. Expected presence of
only plasmatocytes and crystal cells. Observed under 200x magnification.
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Figure 7: Image of 28138 male larvae bleeds without any treatment. Observed under 200x
magnification.

Figure 8: Image of 29658 larvae hemocyte bleeds without any treatment. One of the four genotypes
that showed a presence of lamellocytes without treatment. Red arrows indicate the lamellocytes.
Observed under 200x magnification.
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Figure 9: Distribution of average number of crystal cells across untreated DGRP lines. Left graph is
the bar graph of the average number of crystals per genotype with indicated for lamellocytes. Orange
arrows indicate the genotypes that showed presence of lamellocytes without any treatment. Empty bars
indicate lack of data of average crystal cell number for the genotype. Right is the box-and-whisker plot of
the quartile distribution of average number of crystal cells for all lines.

A total of 41 DGRP genotypes were observed for the presence of lamellocytes. The
genotypes were observed in their untreated state. Out of the 41 genotypes, 4 of them showed the
presence of lamellocytes. This result was unexpected because lamellocytes are only supposed to
be induced when the larvae are infected with wasp parasitoid eggs or foreign pathogens. There
was no correlation between crystal cell count and presence of lamellocytes. The genotypes
ranged from low to average to high average number of crystal cells.
To make sure that an even distribution of average crystal cells was accounted for, simple
statistical measures were calculated. Within the 41 genotypes that were observed, there was a
22

reasonably normal distribution. The average number of crystal cells within these genotypes
ranged from 5 to 742. The median was found to be 260 and mean was found to be 281.92. There
was positive skewness and was calculated to be 0.6532 and kurtosis was calculated to be -0.1702
and light-tailed. The skewness and kurtosis fall within reasonable bounds of normal distribution.

Genome Wide Association Study (GWAS) of untreated DGRP lines
Manhattan plot of associated single nucleotide polymorphisms (SNPs)
Using the lamellocyte presence/absence data for 41 DGRP lines, we performed a GWAS
using the Mackay pipeline (Mackay et al., 2012). Manhattan plots indicate on which
chromosomes the SNPs are located on. They also indicate the strength of the p-value of each
SNP. A Manhattan plot was created to show the genomic distribution of the single nucleotide
polymorphisms (SNPs) associated with lamellocyte formation under control conditions. The
largest number of SNPs were found in the left arm of chromosome 2. The GWAS also showed
that there were insertion and deletion polymorphisms in addition to the SNPs among the
genotypes. Interestingly, 4 out of the top 10 SNPs were located in genes that were associated
with hematopoiesis and immune systems. These genes are Slc45-1, dlg1, Ptp99A, and tlk, circled
in red in figure 10.
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Figure 10: Manhattan plot of the location of the SNPs on Drosophila chromosomes. Each dot
represents one SNP. L and R indicate arms of numbered chromosomes. The 9 SNPs with the lowest pvalues are labeled with each of their gene names. Red circles indicate the SNP on a gene that is associated
with hematopoiesis or immune system.

Figure 11: Summary tables of the SNPs from GWAS. Left table indicates the number of
polymorphisms found in each of the chromosomes. Right table indicates the number of hits for each type
of polymorphism.
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The SNPs were found on varying regions of the genes. They were located in regions
where gene expression may be affected such as in introns, 3’-UTR regions, upstream, and
downstream. Some of the SNPs led to non-synonymous and synonymous changes in the coding
regions. Large percentage of the SNPs (73.15%) were found to be in the intron of the genes. This
is expected as the sequence of introns are 4-5 times the length of sequences of exons (Jo and
Choi, 2015).

Table 1: Number of polymorphisms for different locations within each gene.
Location of SNP in the gene
Codon change + Codon deletion
Downstream
Exon
Intron
Non-synonymous coding
Synonymous coding
Synonymous stop
Upstream
UTR-3-Prime
UTR-5-Prime
Total

# of SNPs
1
14
4
267
7
27
2
23
17
3
365
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QQ plot of Genotypes used for GWAS

Figure 12: QQ plot of the SNP results from the GWAS. Red line indicates the expected normal
distribution of p-value for the SNPs.

To account for other confounding variables that may be associated with the SNPs, a QQ
plot was created along with GWAS through the Mackay DGRP pipeline in figure 13. The
straight diagonal line in the QQ plot indicates the expected distribution of association statistics
across chromosomes (Barrett, 2010). The deviations from the X=Y expected line at the end of
the curve indicate the true associations SNPs and the lamellocyte formation phenotype (Barrett,
2010).
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Characterization of the Genes with SNPs from GWAS
The 365 polymorphisms associated with lamellocyte presence mapped to 180 genes.
Using FlyMine, we discovered their ontology, related pathways, and protein associations. The
key words for the organization of all the genes were immune system, cell differentiation, cell
proliferation and hematopoiesis. From all of the GWAS hits, 44 genes were found to be related
to these key words.
Table 2: Ontological characterization of GWAS hits. Only genes with association with
hematopoiesis or immune system are listed from the GWAS results.
Gene
symbol
spi

FlyBase ID
FBgn0005672

tup
stan
Mad
ed

FBgn0003896
FBgn0024836
FBgn0011648
FBgn0000547

LRR

FBgn0033212

hop

FBgn0004864

msn
pnt

FBgn0010909
FBgn0003118

dlg1

FBgn0001624

sgg

FBgn0003371

dpr9
Tlk

FBgn0038282
FBgn0283657

Ontology
positive regulation of cell proliferation, stem cell fate
commitment
lymph gland development
negative regulation of Notch signaling pathway
regulation of cell differentiation
regulation of cell shape, regulation of hippo signaling, negative
regulation of hippo signaling, wound healing
immune response, response to insecticide, negative regulation
of immune response
immune response, humoral immune response, cellular defense
response, JAK-STAT cascade, tyrosine phosphorylation of
STAT protein, STAT protein import into nucleus,
hematopoiesis, larval lymph gland hematopoiesis, lamellocyte
differentiation, regulation of hemocyte differentiation,
regulation of hemocyte differentiation, regulation of JAKSTAT cascade
regulation of cell shape
positive regulation of cell proliferation, regulation of hemocyte
differentiation
negative regulation of cell proliferation, regulation of Notch
signaling pathway, regulation of cell proliferation, regulation
of JAK-STAT cascade, behavioral response to ethanol
Notch signaling pathway, regulation of hemocyte
differentiation
behavioral response to ethanol
antimicrobial humoral response
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N

FBgn0004647

embryonic hemopoiesis, embryonic crystal cell differentiation,
larval lymph gland hematopoiesis, lymph gland crystal cell
differentiation, lamellocyte differentiation, negative regulation
of lamellocyte differentiation, crystal cell differentiation,
regulation of crystal cell differentiation, positive regulation of
crystal cell differentiation, positive regulation of Notch
signaling pathway, lymph gland development

sl
DCXEMAP
Lmpt
Sik3
Traf-like
CTPsyn
CG5044
Ge-1
dop
bab2
Ptp61F

FBgn0003416
FBgn0259099

negative regulation of cell differentiation
melanotic encapsulation of foreign target

FBgn0261565
FBgn0262103
FBgn0030748
FBgn0266452
FBgn0038326
FBgn0283682
FBgn0267390
FBgn0025525
FBgn0267487

rut

FBgn0003301

defense response to fungus
cellular response to hormone stimulus
immune response
larval lymph gland hemopoiesis
negative regulation of response to wounding
defense response to fungus
regulation of interleukin-12 biosynthetic process
regulation of stem cell differentiation
negative regulation of cell proliferation, negative regulation of
JAK-STAT cascade
behavioral response to ethanol

Table 3: Relevant pathway characterization of GWAS hits.
Gene
symbol
mbc
olf186-F
ATP8B
Hop
sgg
IA-2
CG32264

Mical
kek3
Pde9
RapGAP1
Tmc

Pathways
Innate immune system, Immune system, Neutrophil degranulation, Factors
involved in megakaryocyte development and platelet production
Adaptive Immune System, Immune system, Antigen activates B Cell Receptor
leading to generation of second messengers, Signaling by the B Cell Receptor
Innate Immune System, Immune system, Neutrophil degranulation
HSP90 chaperone cycle for steroid hormone receptors (SHR)
Hedgehog signaling pathway
Innate Immune System, Immune system, Neutrophil degranulation
Platelet degranulation, Platelet activation, signaling and aggregation, Adaptive
immune system, immune system, Antigen processing: ubiquitination &
proteasome degradation, Class I MHC mediated antigen processing &
presentation
Factors involved in megakaryocyte development and platelet production
Platelet degranulation, platelet activation, signaling and aggregation
Platelet homeostasis
Adaptive Immune System, Immune system
Innate Immune System, Immune system, Neutrophil degranulation
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CG5886
JIL-1
Cp1
CCT2
Cam
Ptp61F
rut

Cytokine Signaling in Immune system, Immune system, Signaling by
Interleukins
Cytokine Signaling in Immune system, Toll Like Receptor cascade, Innate
immune system, Immune system
Adaptive Immune System, Innate immune system, Immune system, Toll-Like
Receptor cascades, MHC class II antigen presentation
Innate Immune System, Immune system, Neutrophil degranulation
Innate Immune System, Immune system
Cytokine Signaling in Immune system, Signal transduction, Immune system,
Platelet activation, signaling and aggregation, Interferon gamma signaling
Innate Immune System, Immune system

Table 4: Relevant protein characterization of GWAS hits.
Gene
Protein Domain Name
CG10702 Immunoglobulin-like fold
Ptp99A
PTP type protein phosphatase, Protein-tyrosine phosphatase, catalytic,
Immunoglobulin-like domain, Immunoglobulin-like fold
ed
dpr6
beat-IIIc
Ptp52F

Immunoglobulin-like domain, Immunoglobulin-like fold
Immunoglobulin-like domain, Immunoglobulin-like fold
Immunoglobulin-like domain, Immunoglobulin-like fold
PTP type protein phosphatase, Protein-tyrosine phosphatase, catalytic,
Immunoglobulin-like fold
DIP-theta Immunoglobulin-like domain, Immunoglobulin-like fold
IA-2
PTP type protein phosphatase, Protein-tyrosine phosphatase, catalytic
hiw
Immunoglobulin-like fold
zormin
Immunoglobulin-like domain, Immunoglobulin-like fold
dpr9
Immunoglobulin-like domain, Immunoglobulin-like fold
CG34371 Immunoglobulin-like domain, Immunoglobulin-like fold
kek3
Immunoglobulin-like domain, Immunoglobulin-like fold
CG44153 Immunoglobulin-like domain, Immunoglobulin-like fold
CadN
Immunoglobulin-like fold
Ptp61F
PTP type protein phosphatase, protein-tyrosine phosphatase, catalytic
According to previously established relation to hematopoiesis and immune system for
these genes, they were selected to be genes of interest for further experiments. Three most
important genes to highlight are hop, msn, and N. hopscotch is an essential component of the
JAK-STAT pathway, a pathway that has been shown to be associated with lamellocyte
differentiation (Bina and Ziedler, 2000-2013). In addition, msn has a lamellocyte-active enhancer
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(Tokusumi et al., 2009). Lastly, N is the Notch gene that is important for lamellocyte
differentiation upon infection (Duvic et al, 2002).

Table 5: Location of SNP of genes of interest. Only SNPS with location other than the introns
shown.
Gene
hop
hop
Traf-like
mbc
JIL-1
sl
Cam
CG5886
zormin
kek3
kek3
pnt

SNP location
Synonymous coding at protein coding region
Synonymous coding at protein coding region
UTR_3_PRIME
Synonymous coding at protein coding region
Upstream
UTR_3_PRIME
UTR_3_PRIME
UTR_3_PRIME
Synonymous coding at protein coding region
Upstream
Upstream
Downstream

Most of the location of the SNPs were within the introns of the genes of interest, which
may also change gene expression. However, some of the SNPs were located in regions where
they may affect the expression of the gene. Especially in regions like 3’ Untranslated Regions (3’
UTR), which has been known to be involved in regulatory processes such as polyadenylation and
transcript cleavage, it is likely that gene expression is affected by the SNPs.
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DIOPT-DIST results
Upon using the DIOPT-DIST for human diseases of the Drosophila orthologues, we
found that there were various genes of interest from our study that have already been associated
with autoimmune diseases and other immune system diseases in humans. There were multiple
genes with human orthologues that are connected to common autoimmune diseases such as
celiac disease, psoriasis, rheumatoid arthritis, Crohn’s diseases and systemic lupus
erythematosus. The DIOPT score indicates the similarity in protein alignment of the Drosophila
gene to the human ortholog.
Table 6: Genes with immune system related disorders in human orthologs. Result of only
the genes with the top 10 DIOPT scores

FBgn0266452

Fly
Symbol
CTPsyn

Human
Symbol
CTPS1

DIOPT
Score
14

FBgn0003118

pnt

ETS1

12

FBgn0004864

hop

JAK2

11

FBgn0267487

Ptp61F

PTPN2

10

FBgn0003416

sl

PLCG2

10

FBgn0041585

olf186-F

ORAI1

9

FBgn0004647

N

NOTCH4

5

FBgn0030748 Traf-like

TRAF6

3

FBgn0267487

Ptp61F

PTPN22

2

FBgn0003118

pnt

ERG

2

FlyBaseID

Related Human Disease
Immunodeficiency
Celiac disease, follicular lymphoma,
psoriasis, psoriasis vulgaris,
rheumatoid arthritis, systemic lupus
erythematosus
Crohn's disease
Celiac disease, rheumatoid arthritis,
Crohn's disease, type-1 diabetes
Autoinflammation, antibody
deficiency, immune dysregulation,
familial cold autoinflammatory
syndrome
Immunodeficiency
Crohn's disease, lupus nephritis,
systemic lupus erythematosus, systemic
sclerosis, type-1 diabetes, autoimmune
thyroid diseases, ulcerative colitis
Rheumatoid arthritis
Crohn's disease, pediatric autoimmune
diseases, rheumatoid arthritis, systemic
lupus erythematosus, type-1 diabetes,
autoimmune thyroid diseases, lupus
nephritis
Neonatal lupus
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Expression in Drosophila tissues
We also analyzed whether the 44 genes of interest that resulted from the GWAS had high or low
levels of epression in various tissues (Figure 15).

Figure 13: Number of genes of interest expressed in each tissue of Drosophila melanogaster.
White bar indicates the number of genes with low expression level. Black bar indicates the
number of genes with high expression level.

It was evident from the analysis that a large number of genes were highly expressed in
the larval central nervous system, adult brain and adult thoracicoabdominal ganglion. The largest
number of genes of interest with low expression level were in the testis and virgin spermatheca.
Out of all of the tissues that we had data for, we looked to see the level of high expression
in these top three tissues of the genes of interest. The result enrichment in the y-axes of graphs
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below indicates the Fly Atlas measurement of how much higher or lower the expression level is
in that particular tissue than in the whole fly (Figure 15). In those tissues that expressed high
levels of the genes of interest, we looked to see if any of our genes of interest had low levels of
expression.
The expression levels for the larval or adult lymph gland were not available through
FlyMine. In future experiments, those expression levels should be observed as hematopoiesis
occurs in the larval lymph gland.
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Expression Level in Tissues with Largest Number of Genes with High Levels of Expression

Figure 14: Level of expression compared to the whole fly in the larval CNS. The genes with mRNA
enrichment results below 1 show genes that have lower expression in the larval CNS. The genes with
mRNA enrichment results above 1 show genes that have higher expression in the larval CNS.

35 of the 44 genes (79.5%) were highly expressed in the larval CNS. The level of high
expression varies from above 1 to 28.18. stan showed the highest level of expression in the larval
CNS. stan has been known to be involved in the negative regulation of Notch signaling (Capilla
et al., 2012).
7 out of 44 genes of interest (15.9%) showed lower expression in the larval CNS
compared to the whole fly. The extent of the downregulation of these ranged from 0.18 to 0.76.
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Lmpt showed the least level of expression in the larval CNS compared to the whole fly. Lmpt has
been shown to be involved in the antifungal immune responses (Jin et al., 2008).

Figure 15: Level of expression compared to the whole fly in the brain. The genes with mRNA
enrichment results below 1 show genes that have lower expression in the brain. The genes with mRNA
enrichment results above 1 show genes that have higher expression in the brain.

29 out of 44 genes (65.9%) were shown to be highly expressed in the brain compared to
the whole fly (Figure 17). The levels of high expression ranged from 1.5 to 30.9. The gene that
showed the highest level of expression in the brain was dpr9. It is a gene that belongs in the
immunoglobulin superfamily and has been linked to be involved in the behavioral response to
ethanol and synapse organization (Kong et al, 2010; Carrillo et al, 2015).
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13 out of 44 genes (29.5%) showed low levels of expression in the brain compared to the
whole fly. The levels of low expression ranged from 0.1 to 0.9. The gene that showed the lowest
level of expression was Traf-like. This gene has been shown to act downstream of Toll pathway
according to Flybase database on Traf-like.

Figure 16: Level of expression compared to the whole fly in the thoracicoabdominal ganglion. The
genes with mRNA enrichment results below 1 show genes that have lower expression in the larval CNS.
The genes with mRNA enrichment results above 1 show genes that have higher expression in the larval
CNS.

32 out of 44 genes (72.7%) of the gene of interest showed high levels of expression in the
thoricacoabdmonial ganglion compared to the whole fly (Figure 18). The levels of expression
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range from 1.2 to 29.9. beat-IIIc showed the highest expression in this tissue. It belongs to the
immunoglobulin superfamily of proteins. It has been shown to have immunoglobulin domains
that functions as an anti-adhesive factor that promotes axon defasciculation (Pipe et al., 2002).
13 out of the 44 genes (29.5%) showed low levels of expression in the thoracicoabominal
ganglion compared to the whole fly. The range of low expression was between 0.3 to 0.8. The
Hop, Traf-like, and Ptp61F showed the lowest levels of expression in the thoracicoabdominal
ganglion. Hop gene is also known as the Stressed induced phosphoprotein-1 (stip-1). The
molecular function and the biological processes it is involved in is unknown. The Traf-like gene
as mentioned previously, acts downstream of the Toll pathway (Flybase). The Ptp61F gene acts
as a negative regulator of the JAK-STAT pathway, which is critical in lamellocyte formation
(Muller et al., 2005).
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Network of Interaction among Genes from GWAS

Figure 17: Network of all genes from GWAS results. Dashed lines indicate genetic interaction. Solid
lines indicate physical interaction. The genes filled with blue indicate genes of interest associated with
cell differentiation, cell proliferation, and immune system.

By submitting the list of all genes from GWAS into FlyMine, the ESYN software
produced a map of genes related to each other either genetically or physically. It uses previously
available data in order to determine interactions between genes. There were multiple genes that
were related to hematopoiesis and immune systems interacting with each other as well as with
other genes that resulted from the GWAS that was conducted (Figure 19). It suggests that certain
genes may work together to induce lamellocytes.
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Part III: Effects of Treatments
Control Condition – Ethanol Treatment
As control for the Methoprene treatment, the DGRP lines were also treated with 25μl of ethanol.
Ethanol treatment was considered as the control for the Methoprene treatment because it is an
agent that is present in fermented food such as fruits that Drosophila normally eat.

Figure 18: Image of hemocyte bleed of ethanol treated 28167-genotype female larvae. There is only
presence of plasmatocytes and crystal cells as expected. Observed under 200x magnification.
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Figure 19: Image of hemocyte bleed of ethanol treated 28145-genotype larvae. Observed under 200x
magnification.

Figure 20: Image of hemocyte bleed of ethanol treated 28165-genotype male larvae. Lamellocytes
indicated by red arrows. Observed under 200x magnification. Unexpectedly, it shows presence of
lamellocytes. The number of lamellocytes present is low.
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Figure 21: Image of hemocyte bleed of ethanol treated 29653 genotype female larvae. Yellow arrows
indicate enlarged plasmatocytes. Observed under 200x magnification.

Some genotypes treated with ethanol showed plasmatocytes that were larger than normal.
However, they were not large enough to be considered as lamellocytes. They also had pseudopod
like structures, so they were categorized as plasmatocytes.
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Figure 22: Distribution of average number of crystal cells across ethanol treated DGRP lines. Left
graph is the bar graph of the average number of crystals per genotype with indicated for lamellocytes.
Green arrows indicate the genotypes that showed presence of lamellocytes with ethanol treatment. Empty
bars indicate lack of data of average crystal cell number for the genotype. Right is the box-and-whisker
plot of the quartile distribution of average number of crystal cells with ethanol treatment.

Surprisingly, several genotypes that were treated with ethanol showed presence of
lamellocytes (Figure 24). There were six genotypes that 28146, 29651, 25203, 29658, 28250 and
28165 with presence of lamellocytes. Two of the genotypes, 28146 and 29651, that formed
lamellocyte with ethanol treatment were the same as the genotypes that formed lamellocytes
without any treatment. From observing the number of average crystal cells in these genotypes,
there was also not a correlation between the number of crystal cells and induction of
lamellocytes. The average number of crystal cell distribution was checked for normal
distribution also because not all genotypes from the untreated condition were checked. There was
a reasonable normal distribution of the crystal cell counts based on the skewness and kurtosis
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tests. The skewness of crystal cell counts of the ethanol treated lines was 0.8105. The kurtosis
was light-tailed at value of 0.2088.
A GWAS was conducted with the 31 ethanol treated genotypes because there were some
genotypes that indicated presence of lamellocytes that did not show presence of lamellocytes
without any treatment. On the contrary to the 365 SNPs of the untreated DGRP lines, only 14
SNPs were found for the ethanol treated DGRP lines. The 14 SNPs were located within 10
Drosophila genes. There was only one gene, CG42339, that is associated with immune systems
within this group of genes. It was associated with immune response from electronic inference
from the Flybase Curators, Swiss-Prot Project members and InterPro Project members in their
quest to assign ontology to each gene (flybase.org). From the DIOPT-DIST software, SNP in the
human ortholog for this gene has been associated with Crohn’s disease.

Figure 23: Summary of SNPs for ethanol treated DGRP lines. Left table indicates the number of SNPs
in each chromosome of the fly. Right table indicates the type of SNP in the gene that resulted from the
GWAS.

It is interesting that more than half of the SNPs were located on the X chromosome while
the other chromosomes showed relatively few SNPs (Figure 25). It differs from the distribution
of SNPs that had resulted from the GWAS from the untreated DGRP lines in which there were
comparatively even distribution among chromosomes.
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Table 7: Number of polymorphisms for different location in the gene. Results from the
GWAS conducted with ethanol treated genotypes.
Location of SNP in the gene
Intron
UTR-5-Prime
Upstream
Total

# of SNPs
10
1
3
14

These SNPs were present in introns, UTR-5-Prime, and upstream location of genes. Most
of the SNPs were located within the intronic regions of the genes. It was similar to the results
from the GWAS of the untreated DGRP lines.
Unexpectedly, there were no overlapping SNPs between the untreated and ethanol treated
GWAS results. As ethanol treatment was also supposed to be another control to the Methoprene
treatment, it was expected that the same genotypes as from the untreated genotypes would show
lamellocytes. There were couple genotypes that showed lamellocytes for both untreated and
ethanol treated.
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Experimental Condition – Methoprene Treatment

Figure 24: Image of the hemocyte bleed of the Methoprene treated 55032-genotype male larvae.
Observed under 200x magnification.

Figure 25: Image of the hemocyte bleed of the Methoprene treated 28250-genotype male larvae.
Observed under 200x magnification.
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Figure 26: Image of hemocyte bleed of the Methoprene treated 28240 female larvae. Observed under
200x magnification.

Some genotypes treated with Methoprene showed enlarged plasmatocytes in addition to
lamellocytes. As with the enlarged plasmatocytes that had appeared with the ethanol treated, the
enlarged plasmatocytes were categorized as plasmatocytes due to the pseudopod-like structures
surrounding the cells. The Methoprene treated DGRP lines had lamellocytes with varied sizes
and shapes as shown by figure 30.

Figure 27: Different sizes and shapes of lamellocytes. Lamellocytes from different Methoprene treated
DGRP lines. Observed under 200x magnification.
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Although all genotypes that had been treated for Methoprene showed a presence of
lamellocytes, there was a variation in the number of lamellocytes present. It was not quantified,
but within the same field of view from the microscope, it was clear that there were varying
numbers of lamellocytes between genotypes. It can be seen by comparing figures 28, 29, and 30.
These three genotypes all showed a presence of lamellocytes but the 28240 Methoprene treated
genotypes does not show as many lamellocytes as the other two genotypes. For future
experiments, it will be interesting to also quantify for the number of lamellocytes in addition to
observing for their presence.

Figure 28: Distribution of average number of crystal cells across Methoprene treated DGRP lines.
Left graph is the bar graph of the average number of crystals per genotype with indicated for
lamellocytes. Blue arrows indicate the genotypes that showed presence of lamellocytes without any
treatment. Empty bars indicate lack of data of average crystal cell number for the genotype. Right is the
box-and-whisker plot of the quartile distribution of average number of crystal cells with Methoprene
treatment.
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As with the untreated and ethanol treated genotypes, there was variation in the average
number of crystal cells in the DGRP lines when treated with Methoprene. The skewness and
kurtosis were calculated for the Methoprene treated DGRP lines as couple genotypes differed
from the ethanol treated DGRP lines. The skewness was found to be 0.8583. The kurtosis was
light-tailed and calculated to be -0.1418. All genotypes treated with Methoprene showed a
presence of lamellocytes. Most hemocyte bleeds showed a large amount of lamellocytes for each
well that was made. Because all genotypes had lamellocytes, a GWAS could not be conducted
for the Methoprene treated DGRP lines.
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Comparison of Lamellocyte Presence for Untreated and Treated DGRP Lines

Figure 29: List of genotypes that have been observed for lamellocytes in untreated, ethanol treated,
and Methoprene treated conditions. Blue boxes indicate genotype and treatment with presence of
lamellocytes.

A total of 26 DGRP lines were completely observed for lamellocytes under untreated,
ethanol treated, and Methoprene treated conditions. Two of the genotypes showed presence of
lamellocytes in the untreated and ethanol treatment. However, the unanticipated presence of
lamellocytes in untreated lines did not necessarily lead to presence of lamellocytes in the same
DGRP lines after ethanol treatment as one genotype that showed lamellocytes in untreated
conditions did not have lamellocytes under ethanol treatments. Furthermore, there were two
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genotypes that did not show lamellocytes in its untreated state but had lamellocytes upon ethanol
treatments. As can also be seen by figure 32, it was evident that Methoprene treatment led to
lamellocyte induction for all the DGRP lines that were used during this experiment.
Although the exact number of lamellocytes were not quantified, it was clear of the
difference in quantity of lamellocytes in the different treatments. With almost all of the
genotypes that showed presence of lamellocytes in the untreated and ethanol treated lines, the
quantity of lamellocytes in the well were low. Only one genotype 29658 had a high quantity of
lamellocytes in the untreated and ethanol treated state. Compared to the untreated and ethanol
treated DGRP hemocyte stains, the Methoprene treated DGRP hemocyte stains showed a higher
quantity of lamellocytes in all lines.
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Immunofluorescence Hemocyte Stains of All DGRP Lines Used
No Treatment
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Ethanol Treatment
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55

Methoprene Treatment
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Comparison of DGRP Lines to Previous Tumor Data
It has been shown that melanotic tumors are linked to hemocyte-mediated immune
response (Minakhina and Steward, 2006). To be more specific, the melanotic tumors are results
of elevated JAK-STAT signaling, which is the signaling pathway for lamellocyte induction
(Anderson et al, 2017). To see if the formation of melanotic tumors were related to the formation
of lamellocytes after Methoprene treatment, data from previous work in the Spokony lab were
compared to the results of the lamellocyte induction of this study. Previously experiments in the
Spokony lab had measured the percent of larvae with tumors after Methoprene treatment (Figure
33). The treatments had been done the same way as with the treatment for this study.

Figure 30: Percentage of DGRP line larvae with tumors upon Methoprene treatment. Only shown
for the genotypes that had been used for the hemocyte immunofluorescence staining.
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Within these DGRP lines, the induction of lamellocytes did not necessarily correspond
the formation of melanotic tumors following treatment with Methoprene. Half of the genotypes
that did not form melanotic tumors upon Methoprene treatment also show induction of
lamellocytes under the same conditions. The remaining 7 genotypes all showed melanotic tumors
and lamellocyte following treatment.

Comparison of Gene of Interest to Previous Methoprene-Treated Microarray
Since all the genotypes showed a presence of lamellocytes when treated with
Methoprene, we checked to see if any of the genes of interest from the GWAS for untreated
DGRP lines was differentially expressed after Methoprene treatment. We compared the list of
genes of interest from a microarray study had been done previously in the Spokony lab (Table 8).

Table 8: List of genes associated with lamellocyte formation and differentially expressed
upon Methoprene treatment in the brain, whole animal and culture cells.
Name
Brain
discs large 1
Ge-1
shaggy
zormin
CG32264
Protein tyrosine phosphatase 99A
Whole Animal
Ptp52F
bric a brac 2
discs large 1
Culture Cells
hopscotch
Protein tyrosine phosphatase 99A

Symbol
dlg1
Ge-1
sgg
zormin
CG32264
Ptp99A
Ptp52F
bab2
dlg1
hop
Ptp99A
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There were 6 genes from the ones narrowed down from the GWAS study with untreated
DGRP lines that were differentially expressed upon Methoprene treatment. It was interesting that
hop was shown to be differentially expressed in the culture cells upon Methoprene treatment as it
is one of key genes involved in lamellocyte induction pathway. As the next step, to gain a better
understanding of how Methoprene can possibly target these genes and induce lamellocytes,
further analysis on the level of differential expression should be measured.
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Discussion
Contrary to previous literature on lamellocyte induction, there were DGRP lines larvae
that showed presence of lamellocytes without any attack from wasp parasitoids or other foreign
agents (Crozatier and Meister, 2007; Wang et al., 2014; Sorrentino et al., 2002). Through
comparison of the hemocyte bleeds of the DGRP lines with a GWAS, SNPs related to
lamellocyte induction were found. Although the total number of SNPs was 365, there were 44
SNPs in genes related to hematopoiesis and immune systems that became genes of interest for
further analyses. The SNPs were found in genes that were involved in well-known lamellocyte
induction pathways and have human orthologs associated with autoimmune diseases such as hop,
msn, and Notch.
It was intriguing that many genes of interest were highly expressed in central nervous
system related tissues. It aligns with the increase in current research in the relationship between
the nervous system and the immune system. Deeper research is warranted to explore the genes
highly expressed in nervous system related tissues. Furthermore, it would be helpful to measure
the level of expression of these genes in the lymph gland and other immune system related
tissues as mentioned previously.
There were multiple human orthologs of the genes of interests that had previously been
shown to be associated with autoimmune diseases and immunodeficiency. Common autoimmune
diseases that were associated with the human orthologs were rheumatoid arthritis, multiple
sclerosis, and systemic lupus erythematosus. Combined, they affect an estimated amount of 3.2
million people in the United States alone (Rhematoid Arthritis Support Foundation; Healthline;
Lupus Foundation of America). There seems to be some connection between the genes
associated with the induction of lamellocytes and autoimmune diseases.
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In addition to the unexpected lamellocyte formation in the untreated DGRP lines, the
ethanol treated DGRP lines also showed unexpected presence of lamellocytes. GWAS conducted
for the ethanol treated lines showed 14 SNPs which was considerably less than the SNPs for the
untreated lines. There was only one gene with a SNP that was related to the immune system, the
CG42339 gene. None of the SNPs from the ethanol treated GWAS matched with the GWAS
results from the untreated lines.
All the DGRP lines displayed a presence of lamellocytes when treated with Methoprene.
Although it had been hypothesized that some lines would induce lamellocytes with Methoprene,
it was unexpected that all would show presence of lamellocytes. GWAS could not be conducted
for the Methoprene treated lines because all lines had presence of lamellocytes. As a GWAS
cannot be conducted for Methoprene treated lines, future directions of the experiment include
measuring the expression levels of the genes of interest identified from the untreated DGRP line
GWAS. As preliminary comparison has already shown that some genes of interest are
differentially expressed when Drosophila are treated with Methoprene, it would provide a more
comprehensive understanding of how Methoprene affects certain genes to induce lamellocytes.
Furthermore, more functional validation of the genes in which SNPs were present are needed for
comprehending the role of these genes in lamellocyte induction.
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Conclusion
As with many Genome Wide Association Studies, the results from this study provides the
foundation for further research into genetic and environmental factors of hemocyte
differentiation. Additional functional validation studies will provide a better understanding of if
and how these genes work during formation of lamellocytes. This will lead to new targets for
human blood disease therapies and drug discovery processes. Follow-up experiments examining
human cell response to Methoprene will determine if hematopoiesis is altered by pesticide
exposure and will offer better explanations of how environmental factors can trigger autoimmune
diseases. With that, there is potential to prevent and help millions of people in the United States
and all over the world suffering from autoimmune diseases.
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